|
1
|
BB Biotech
Schaffhausen,
Switzerland
|
$156M
|
+$5.3M
|
+110,000
|
+3%
|
|
|
2
|
Meditor Group
Hamilton,
Bermuda
|
$123M
|
+$2.41M
|
+50,000
|
+2%
|
|
|
3
|
Pentwater Capital Management
Naples,
Florida
|
$114M
|
+$6.54M
|
+135,800
|
+6%
|
|
|
4
|
PFM Health Sciences
San Francisco,
California
|
$86.4M
|
-$4.39M
|
-91,131
|
-5%
|
|
|
5
|
|
$86.4M
|
-$289
|
-6
|
-0%
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$78.1M
|
+$2.36M
|
+48,902
|
+3%
|
|
|
7
|
State Street
Boston,
Massachusetts
|
$69.3M
|
-$16.3M
|
-338,559
|
-18%
|
|
|
8
|
Boxer Capital
San Diego,
California
|
$55.2M
|
-$8.43M
|
-175,000
|
-13%
|
|
|
9
|
Credit Suisse
Zurich,
Switzerland
|
$44.7M
|
+$52.5K
|
+1,089
|
+0.1%
|
|
|
10
|
Fidelity Investments
Boston,
Massachusetts
|
$34M
|
+$10.9M
|
+225,205
|
+44%
|
|
|
11
|
Wasatch Advisors
Salt Lake City,
Utah
|
$25.9M
|
+$257K
|
+5,339
|
+1%
|
|
|
12
|
Aviva Holdings
New Providence,
Bahamas
|
$21.4M
|
-$35.4M
|
-735,451
|
-61%
|
|
|
13
|
Nomura Holdings
Tokyo,
Japan
|
$21.3M
|
+$8.9M
|
+184,700
|
+66%
|
|
|
14
|
Bellevue Group
Kuesnacht,
Switzerland
|
$20.8M
|
+$2.9M
|
+60,120
|
+15%
|
|
|
15
|
Pictet Asset Management (UK)
London,
United Kingdom
|
$17.7M
|
-$350K
|
-7,262
|
-2%
|
|
|
16
|
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
$16.3M
|
–
|
–
|
–
|
|
|
17
|
|
$15.1M
|
+$4.54M
|
+94,319
|
+40%
|
|
|
18
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$13.6M
|
-$307K
|
-6,363
|
-2%
|
|
|
19
|
Northern Trust
Chicago,
Illinois
|
$13.2M
|
-$16.3M
|
-338,812
|
-54%
|
|
|
20
|
Geode Capital Management
Boston,
Massachusetts
|
$12.7M
|
+$983K
|
+20,403
|
+8%
|
|
|
21
|
Amundi Asset Management US
Boston,
Massachusetts
|
$12.6M
|
-$3.34M
|
-69,233
|
-20%
|
|
|
22
|
|
$11.1M
|
+$6.08M
|
+126,116
|
+110%
|
|
|
23
|
HSBC Holdings
London,
United Kingdom
|
$11.1M
|
+$11.6M
|
+240,590
|
New
|
|
|
24
|
Spark Investment Management
New York
|
$10.4M
|
+$4.97M
|
+103,100
|
+83%
|
|
|
25
|
|
$9.36M
|
+$6.38M
|
+132,343
|
+186%
|
|
